kre-alkalyn

INDUSTRY & RESEARCH

March 1, 2017

Kre-Alkalyn® Buffered Creatine Awarded Third International Patent

March 1, 2017 FOR IMMEDIATE RELEASE Contact: Jeff Golini, Executive Scientist Email:  jeffg@allamericanpharmaceutical.com Phone: 1-406-245-5793 Kre-Alkalyn® Buffered Creatine Awarded Third International Patent Billings, MT. – Nutritional supplement […]
July 8, 2016

Kre-Alkalyn® Alert: Tri-Pharm Kre-Alkalyn® Product Is Counterfeit

All American Pharmaceutical has just become aware that TriPharm is selling a counterfeit Kre-Alkalyn®  product labeled  K4. This product is not licensed and has been declared […]
January 20, 2016

Science For Humans #1796: What’s The Big Deal About Kre-Alkalyn?

Kyle from Ohio gets his question answered about Kre-Alkalyn.
November 9, 2015

Study: Effects of Kre-Alkalyn® On Cell Membranes, Protein Synthesis, And Cellular Toxicity

The Effect of an Alkaline Buffered Creatine (Kre-Alkalyn®), on Cell Membrane Behavior, Protein Synthesis, And Cisplatin-Mediated Cellular Toxicity Jeff Golini, PhD. All American Pharmaceutical, Billings Montana […]
October 27, 2015

Kre-Alkalyn® Research Article Published In Emory University School Of Medicine Peer-Reviewed Journal

Billings-based All American Pharmaceutical is pleased to announce that Dr. Jeff Golini’s research article, “The Effect of an Alkaline Buffered Creatine (Kre-Alkalyn®), on Cell Membrane Behavior, […]
October 10, 2015

Study: Kre-Alkalyn® Compared to Creatine In Olympic Weightlifters

A Double-Blind Comparative Trial of Kre-Alkalyn to Creatine in Olympic Weightlifters Dr. Jeff Golini, Dr. Kamen Stroychev and Dr. Neno Terziiski All American Pharmaceutical, Billings, MT, […]